Nanjing Vazyme Biotech Co., Ltd (SHA:688105)

China · Delayed Price · Currency is CNY

24.24

-1.28 (-5.02%)

Aug 21, 2026, 3:00 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Research and Experimental Development	1.17B	-	-				-	-
Pharmaceutical Manufacturing	202.94M	-	-				-	-
Diagnostic Kits / Equipment	-	-	-				268.38M	170.80M
Total	1.37B	-	-				268.38M	170.80M

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
China	1.20B	-	-				262.72M	163.49M
Overseas	169.34M	-	-				4.47M	1.24M
Total	1.37B	-	-				267.19M	164.72M